Announcements Trials
Browse Landscape

Status

Withdrawn 2Completed 2Recruiting 1Enrolling by invitation 1Available 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 12Hematologic Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Prostatic Neoplasms 5Urinary Bladder Neoplasms 4Leukemia, Myeloid, Acute 4Colorectal Neoplasms 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Myasthenia Gravis 3Multiple Myeloma 3Lung Neoplasms 3Kidney Neoplasms 3Carcinoma, Hepatocellular 3Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Heart Failure 2Glioma 2Glioblastoma 2Esophageal Neoplasms 2Diabetes Mellitus, Type 2 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × INDUSTRY × Hearing Loss × Clear all
NCT07503613 2026-04-06

Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy

Akouos, Inc.

Enrolling by invitation
100 enrolled
CNS

Neuroma, Acoustic, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡